282 related articles for article (PubMed ID: 23017135)
1. Negative regulation of myeloid-derived suppressor cells in cancer.
Qu P; Boelte KC; Lin PC
Immunol Invest; 2012; 41(6-7):562-80. PubMed ID: 23017135
[TBL] [Abstract][Full Text] [Related]
2. Immune suppression: the hallmark of myeloid derived suppressor cells.
Haile LA; Greten TF; Korangy F
Immunol Invest; 2012; 41(6-7):581-94. PubMed ID: 23017136
[TBL] [Abstract][Full Text] [Related]
3. Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses.
Solito S; Pinton L; Damuzzo V; Mandruzzato S
Immunol Invest; 2012; 41(6-7):722-37. PubMed ID: 23017143
[TBL] [Abstract][Full Text] [Related]
4. Guest editorial.
Abrams S
Immunol Invest; 2012; 41(6-7):555-61. PubMed ID: 23017134
[No Abstract] [Full Text] [Related]
5. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.
Raber P; Ochoa AC; Rodríguez PC
Immunol Invest; 2012; 41(6-7):614-34. PubMed ID: 23017138
[TBL] [Abstract][Full Text] [Related]
6. Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship.
Monu NR; Frey AB
Immunol Invest; 2012; 41(6-7):595-613. PubMed ID: 23017137
[TBL] [Abstract][Full Text] [Related]
7. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.
Obermajer N; Wong JL; Edwards RP; Odunsi K; Moysich K; Kalinski P
Immunol Invest; 2012; 41(6-7):635-57. PubMed ID: 23017139
[TBL] [Abstract][Full Text] [Related]
8. Letter from the editor.
Rittenhouse-Olson K
Immunol Invest; 2012; 41(6-7):551-4. PubMed ID: 22938016
[No Abstract] [Full Text] [Related]
9. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.
Agresta L; Hoebe KHN; Janssen EM
Front Immunol; 2018; 9():2809. PubMed ID: 30546369
[TBL] [Abstract][Full Text] [Related]
10. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.
Cohen PA; Ko JS; Storkus WJ; Spencer CD; Bradley JM; Gorman JE; McCurry DB; Zorro-Manrique S; Dominguez AL; Pathangey LB; Rayman PA; Rini BI; Gendler SJ; Finke JH
Immunol Invest; 2012; 41(6-7):680-710. PubMed ID: 23017141
[TBL] [Abstract][Full Text] [Related]
12. Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients.
Jiang J; Guo W; Liang X
Hum Immunol; 2014 Nov; 75(11):1128-37. PubMed ID: 25305034
[TBL] [Abstract][Full Text] [Related]
13. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.
Kohanbash G; Okada H
Immunol Invest; 2012; 41(6-7):658-79. PubMed ID: 23017140
[TBL] [Abstract][Full Text] [Related]
14. Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells.
Lee M; Park CS; Lee YR; Im SA; Song S; Lee CK
Arch Pharm Res; 2014; 37(9):1234-40. PubMed ID: 24748512
[TBL] [Abstract][Full Text] [Related]
15. Myeloid derived suppressor cells and their role in diseases.
Kong YY; Fuchsberger M; Xiang SD; Apostolopoulos V; Plebanski M
Curr Med Chem; 2013; 20(11):1437-44. PubMed ID: 23409714
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic plasticity of MDSC in cancers.
Manjili MH
Immunol Invest; 2012; 41(6-7):711-21. PubMed ID: 23017142
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells in Cancers and Inflammatory Diseases: Angel or Demon?
Su Z; Ni P; Zhou C; Wang J
Scand J Immunol; 2016 Nov; 84(5):255-261. PubMed ID: 27541573
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal relationship between myeloid-derived suppressor cells and T cells.
Nagaraj S; Youn JI; Gabrilovich DI
J Immunol; 2013 Jul; 191(1):17-23. PubMed ID: 23794702
[TBL] [Abstract][Full Text] [Related]
19. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
Rodríguez PC; Ochoa AC
Immunol Rev; 2008 Apr; 222():180-91. PubMed ID: 18364002
[TBL] [Abstract][Full Text] [Related]
20. TNF signaling drives myeloid-derived suppressor cell accumulation.
Zhao X; Rong L; Zhao X; Li X; Liu X; Deng J; Wu H; Xu X; Erben U; Wu P; Syrbe U; Sieper J; Qin Z
J Clin Invest; 2012 Nov; 122(11):4094-104. PubMed ID: 23064360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
